|
WO2019091601A1
|
|
Beta-hairpin peptidomimetics
|
|
MX2019009779A
|
|
Pharmaceutical combinations for treating cancer.
|
|
MX2018014425A
|
|
Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof.
|
|
JP2017160247A
|
|
Conformation-locked, synthetic macrocyclic compound
|
|
HK1225398A1
|
|
Beta-hairpin peptidomimetics as selective elastase inhibitors
|
|
WO2017063757A1
|
|
Conformationally constrained macrocyclic compounds
|
|
WO2017063754A1
|
|
Conformationally constrained macrocyclic compounds as pin1 modulators
|
|
WO2017063756A1
|
|
Conformationally constrained macrocyclic compounds as pin1 modulators
|
|
WO2017063755A1
|
|
Conformationally constrained macrocyclic compounds
|
|
US2018072774A1
|
|
Backbone-cyclized peptidomimetics with GLP-1R modulating activity
|
|
WO2016150576A1
|
|
Beta-hairpin peptidomimetics
|
|
CA2963226A1
|
|
Beta-hairpin peptidomimetics
|
|
CN107001425A
|
|
Beta hairpin peptide mimics
|
|
JP2015155430A
|
|
Conformationally constrained, synthetic macrocyclic compounds
|
|
CA2908385A1
|
|
Beta-hairpin peptidomimetics
|
|
NZ722030A
|
|
Beta-hairpin peptidomimetics as selective elastase inhibitors
|
|
NZ722025A
|
|
Beta-hairpin peptidomimetics as selective elastase inhibitors
|
|
BR112015002726A2
|
|
combination, pharmaceutical composition, kit, and uses of a combination, and a pharmaceutical composition
|
|
RS56249B1
|
|
Combinations with a backbone-cyclized peptide
|
|
SG11201405628YA
|
|
Conformationally constrained, fully synthetic macrocyclic compounds
|
